INVITRO APPROACHES TO THE ELUCIDATION OF MECHANISMS OF CHEMICAL TERATOGENESIS

被引:5
作者
WELSCH, F
机构
[1] Chemical Industry Institute of Toxicology, North Carolina, 27709, Research Triangle Park
关键词
D O I
10.1002/tera.1420460103
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
This article describes some of the contributions that in vitro methods have made to our progress, albeit slow, toward understanding mechanisms of chemical teratogenesis. Emphasis is given to the painstaking and time consuming nature of approaches required to elucidate mechanisms. The examples considered are cyclophosphamide, 2-methoxyethanol, and retinoids. Some of the newer methods that take advantage of the recent advances in molecular biology and analytical chemistry have already been applied to studies on teratogenic mechanisms. Prospects for the 1990s are excellent and promise more rapid progress than during the past decade toward unraveling the mysteries of normal developmental biology. That knowledge in turn should be immediately applicable for investigations on developmental toxicant-induced abnormal development.
引用
收藏
页码:3 / 14
页数:12
相关论文
共 31 条
[1]  
BROWN NA, 1982, DEV TOXICOLOGY, P31
[2]  
COCKROFT DL, 1980, ACTA MORPHOL HUNG, V28, P117
[3]  
CREECHKRAFT J, 1987, TOXICOL APPL PHARM, V87, P474
[4]   RETINOIDS AND VERTEBRATE LIMB PATTERN-FORMATION [J].
EICHELE, G .
TRENDS IN GENETICS, 1989, 5 (08) :246-251
[5]   TERATOGENIC BIOACTIVATION OF CYCLOPHOSPHAMIDE INVITRO [J].
FANTEL, AG ;
GREENAWAY, JC ;
JUCHAU, MR ;
SHEPARD, TH .
LIFE SCIENCES, 1979, 25 (01) :67-72
[6]   EFFECT OF PHENOBARBITAL AND SKF 525-A ON TERATOGENICITY OF CYCLOPHOSPHAMIDE IN MICE [J].
GIBSON, JE ;
BECKER, BA .
TERATOLOGY, 1968, 1 (04) :393-&
[7]  
GOULDING EH, 1986, J CRAN GENET DEV BIO, V6, P99
[8]  
HOHORST HJ, 1971, ARZNEI-FORSCHUNG, V21, P1254
[9]   RETINOIC ACID RAPIDLY REDUCES CARTILAGE MATRIX SYNTHESIS BY ALTERING GENE-TRANSCRIPTION IN CHONDROCYTES [J].
HORTON, WE ;
YAMADA, Y ;
HASSELL, JR .
DEVELOPMENTAL BIOLOGY, 1987, 123 (02) :508-516
[10]  
JUCHAU MR, 1989, ANNU REV PHARMACOL, V29, P165